Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018 (2018), Article ID 3981315, 5 pages
https://doi.org/10.1155/2018/3981315
Research Article

Mitochondrial T16189C Polymorphism Is Associated with Metabolic Syndrome in the Mexican Population

1Laboratorio Multidisciplinario de Investigación, Escuela Militar de Graduados de Sanidad, Secretaría de la Defensa Nacional, CP 11200 Ciudad de México, Mexico
2Facultad de Estudios Superiores Cuautitlán Izcalli, UNAM, CP 54740 Cuautitlán, Estado de México, Mexico
3Universidad del Valle de México, Campus Lomas Verdes, CP 53220 Naucalpan de Juárez, Estado de México, Mexico
4Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional, CP 07738 Ciudad de México, Mexico
5Laboratorio de Biomedicina Molecular I, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, CP 07320 Ciudad de México, Mexico

Correspondence should be addressed to Virginia Sánchez-Monroy; moc.liamtoh@71msykciv

Received 4 November 2017; Accepted 11 February 2018; Published 25 March 2018

Academic Editor: Gabriel R. Fries

Copyright © 2018 Elsa Saldaña-Rivera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Rojas Martínez, C. A. Aguilar-Salinas, A. Jimenez-Corona, F. J. Gomez-Perez, S. Barquera, and E. Lazcano-Ponce, “Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension,” Salud Publica Mexico, vol. 54, no. 1, pp. 7–12, 2012. View at Google Scholar
  2. P. Zimmet, K. G. M. M. Alberti, and M. S. Ríos, “A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results,” Revista Española de Cardiología, vol. 58, no. 12, pp. 1371–1376, 2005. View at Publisher · View at Google Scholar
  3. K. G. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Casteels, K. Ong, D. Phillips, H. Bendall, and M. Pembrey, “Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes,” The Lancet, vol. 353, no. 9163, pp. 1499-1500, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-W. Weng, C.-W. Liou, T.-K. Lin et al., “Association of mitochondrial deoxyribonucleic acid 16189 variant (T→C transition) with metabolic syndrome in Chinese adults,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 9, pp. 5037–5040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. V. O. Palmieri, D. De Rasmo, A. Signorile et al., “T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects,” Nutrition, vol. 27, no. 7-8, pp. 773–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Skuratovskaia, J. K. Sofronova, P. A. Zatolokin, M. A. Vasilenko, L. S. Litvinova, and I. O. Mazunin, “The association of the mitochondrial DNA oriB variants with metabolic syndrome,” Biomeditsinskaya Khimiya, vol. 63, no. 6, pp. 533–538, 2017. View at Publisher · View at Google Scholar
  8. Z. Ye, C. Gillson, M. Sims et al., “The association of the mitochondrial DNA OriB variant (16184–16193 polycytosine tract) with type 2 diabetes in Europid populations,” Diabetologia, vol. 56, no. 9, pp. 1907–1913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Poulton, M. Scott Brown, A. Cooper, D. R. Marchington, and D. I. W. Phillips, “A common mitochondrial DNA variant is associated with insulin resistance in adult life,” Diabetologia, vol. 41, no. 1, pp. 54–58, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. K. S. Park, J. C. Chan, L. M. Chuang et al., “A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians,” Diabetologia, vol. 51, no. 4, pp. 602–608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. Lin, S. D. Chen, P. W. Wang et al., “Increased oxidative damage with altered antioxidative status in type 2 diabetic patients harboring the 16189 T to C variant of mitochondrial DNA,” Annals of the New York Academy of Sciences, vol. 1042, no. 1, pp. 64–69, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. W. Liou, T. K. Lin, J. B. Chen et al., “Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells,” Journal of Medical Genetics, vol. 47, no. 11, pp. 723–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yasukawa, M. Y. Yang, H. T. Jacobs, and I. J. Holt, “A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA,” Molecular Cell, vol. 18, no. 6, pp. 651–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Cavelier, E. Jazin, P. Jalonen, and U. Gyllensten, “MtDNA substitution rate and segregation of heteroplasmy in coding and noncoding regions,” Human Genetics, vol. 107, no. 1, pp. 45–50, 2000. View at Publisher · View at Google Scholar
  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar
  16. M. A. Ortiz-Rodríguez, L. Yañez-Velasco, A. Carnevale et al., “Prevalence of metabolic syndrome among elderly Mexicans,” Archives of Gerontology and Geriatrics, vol. 73, pp. 288–293, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. V. M. Miller and S. P. Duckles, “Vascular actions of estrogens: functional implications,” Pharmacological Reviews, vol. 60, no. 2, pp. 210–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. World Health Organization, “Prevalence of overweight, ages 18+, 1975–2014 (age standardized estimate),” 2014, http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/overweight/atlas.html. View at Google Scholar
  19. T. Domínguez-Reyes, I. Quiroz-Vargas, A. B. Salgado-Bernabé, L. Salgado-Goytia, J. F. Muñoz-Valle, and I. Parra-Rojas, “Las medidas antropométricas como indicadores predictivos de riesgo metabólico en una población mexicana,” Nutrición Hospitalaria, vol. 34, no. 1, pp. 96–101, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Crispim, N. J. R. Fagundes, L. H. Canani, J. L. Gross, B. Tschiedel, and I. Roisenberg, “Role of the mitochondrial m.16189T>C variant in type 2 diabetes mellitus in southern Brazil,” Diabetes Research and Clinical Practice, vol. 74, no. 2, pp. 204–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. E. Mueller, W. Eder, S. Ebner et al., “The mitochondrial T16189C polymorphism is associated with coronary artery disease in middle European populations,” PLoS One, vol. 6, no. 1, article e16455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. H. Wilson, A. Hariri, A. Farhi et al., “A cluster of metabolic defects caused by mutation in a mitochondrial tRNA,” Science, vol. 306, no. 5699, pp. 1190–1194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Patti and S. Corvera, “The role of mitochondria in the pathogenesis of type 2 diabetes,” Endocrine Reviews, vol. 31, no. 3, pp. 364–395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Ford, C. Li, and N. Sattar, “Metabolic syndrome and incident diabetes: current state of the evidence,” Diabetes Care, vol. 31, no. 9, pp. 1898–1904, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Gami, B. J. Witt, D. E. Howard et al., “Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies,” Journal of the American College of Cardiology, vol. 49, no. 4, pp. 403–414, 2007. View at Publisher · View at Google Scholar · View at Scopus